Where does Fidelis Partners, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fidelis Partners, LLC ranks #40,192 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fidelis Partners, LLC hold?

Fidelis Partners, LLC holds 6 US utility patents granted between 2024 and 2025, spanning 6 technology areas.

What is Fidelis Partners, LLC's Innovation Score?

Fidelis Partners, LLC has an Innovation Score of 39.0 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Fidelis Partners, LLC focus on?

Fidelis Partners, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents. Grants appear in 6 CPC subclasses total.

Is Fidelis Partners, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Fidelis Partners, LLC.

What does claim depth mean for Fidelis Partners, LLC's patents?

Fidelis Partners, LLC's patents average 17.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fidelis Partners, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Fidelis Partners, LLC

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fidelis ranks #40,192 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#40,192
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.0/100): 17.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R40192 · US Corporation #40,192 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #40,192/49,997
PHOTO-FINISH Feng HE Ying ZAO Group
CPC-NARROW A61B · 6 areas
INNOV-THIN 39.0/100
CLAIMS-RICH 17.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Feng HE Ying ZAO Group Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Fidelis Partners · this assignee

39
3D Lighting… · lowest

7

What this shows Fidelis's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Fidelis's grants concentrate

Fidelis Partners, LLC is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Fidelis sits between Feng HE Ying ZAO Group Co., Ltd. and Filtran LLC.

Fidelis's three-year grant acceleration

Fidelis Partners, LLC shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Feng HE Ying ZAO…

6
Fermob

6
FFF Enterprises

6
Fiac S P A

6
Fidia S P A

6
Fillon

6
Filtereasy

6
Filtran

6
Fidelis Partners ◀

6

What this shows Fidelis holds 6 patents at rank #40,162, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fidelis

By rank, the assignees closest to #40,162 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Fidelis's primary technology class.

Fidelis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

Fidelis Partners, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	2	33.3%
2025partial year	4	66.7%

Which technologies does Fidelis Partners, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

G06F - Electric Digital Data Processing 2

G02B - Optical Elements, Systems OR Apparatus 2

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 1

B25F - Combination OR Multi-purpose Tools NOT Otherwise Provided FOR; Details OR Components OF Portable Power-driven Tools NOT Particularly Related TO THE Operations Performed AND NOT Otherwise Provided FOR 1

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#40,192

of 49,997 tracked assignees

Innovation Score

39.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Fidelis Partners, LLC's patent record in context - here's where to go next.

Fidelis Partners, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #40,192 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fidelis Partners, LLC against Feng HE Ying ZAO Group Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.